NDNB25

N/A

Report date: 2025/04/29 10:26:53
NME

Base Information

Drug NameNDNB25
Drug Alias NameNDNB25NDNB-25
ClassificationSmall molecules
Mechanisms of ActionHeat shock protein HSP 90-beta inhibitors
TargetsHeat shock protein HSP 90-beta
Therapy Area/IndicationsEsophageal adenocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIndiana University School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesIndiana University School Of Medicine
Inactive CompaniesN/A
Active IndicationsEsophageal adenocarcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A